HPV Cancer Prevention


“You Are the Key: Best Practices for HPV Cancer Prevention”
Tuesday, June 12, 2PM EST
Register Now
 Low HPV vaccination rates are leaving boys and girls vulnerable to devastating HPV cancers. Have you been making an effective HPV vaccination recommendation for kids 11 and 12 years old? This presentation will provide up-to-date information on HPV infection/disease, the HPV vaccine, ACIP recommendations, and ways to successfully communicate with patients and their parents about HPV vaccination. Find out how to reduce missed opportunities by recommending HPV vaccine the same way and same day you recommend other routinely recommended adolescent vaccines. Learn best practices from other medical offices across the nation that are making HPV vaccination a priority.
Continuing education credits are pending
Betty Lo, MD, Professor of Clinical Medicine and Pediatrics; Director of Medicine/Pediatrics Residency Program at Louisiana State University School of Medicine
Target Audience
This activity has been designed to meet the educational needs of health professionals who provide and/or promote immunizations including physicians, physician assistants and registered nurses, as well as health professions students.
Educational Objectives
  • Describe the burden of HPV disease.
  • Define the importance of HPV vaccination for cancer prevention.
  • Explain the rationale for vaccinating youth at ages 11 or 12.
  • List the recommendations for administering the HPV vaccine to girls and to boys.
  • Provide useful and compelling information about HPV vaccine to parents to aid in making the decision to vaccinate.
  • Provide resources relevant to current immunization practice.
 For more information, email info@ntc.nationalahec.org.


HPV Education Resources for Healthcare Providers

Continuing Education Course 

Title: “Human Papillomavirus (HPV) Vaccine Safety”

Faculty: Julianne Gee, MPH, Immunization Safety Office, Centers for Disease Control and Prevention

Educational Objectives:

  • Clearly inform participants of vaccine safety systems in the US.
  • Identify and utilize available HPV vaccine safety date.
  • Describe current safety monitoring and evaluation for nine-valent HPV vaccine.
  • Provide appropriate care and counsel for patients and their families.

Credits available:

  • 1 AMA PRA Category 1 Credit™ for physicians
  • 1 ANCC contact hour for nurses

HPV Vaccine Safety CME Course Link

Watch this moving story from an HPV-related cancer survivor. 


WebGraphic (1)

Southeast Pennsylvania Area Health Education Center